Gregory Bailey, Director at Serina Therapeutics, Inc. (SER), bought 18,038 shares at $0.10 ($87K) on 2024-05-28, disclosed to the SEC on 2024-05-29.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.10 | 9,019 | $857 | 1.0% |
| 2 | $9.50 | 9,019 | $86K | 99.0% |
| Total | $4.80 avg | 18,038 | $87K | 100% |
| Filing → |
| BHVN | BUY | 2024-09-25 | $221K | — | Filing → |
| SER | BUY | 2024-09-24 | $7K | — | Filing → |
| SER | BUY | 2024-09-20 | $88K | — | Filing → |